Buy Divi's Laboratories Ltd & SRF Ltd

Buy Divi’s Laboratories Ltd & SRF Ltd

Divi’s Laboratories Ltd (DIVI):

Divi’s Laboratories Ltd has officially announced a consolidated sales of Rs. 1,396.26 Cr for the quarter finished on 31-12-2019, which is -3.41% down from its previous quarter sales of Rs. 1,445.57 Cr and 2.67% up from its previous year’s same quarter sales of Rs. 1,359.96 Cr. The firm has also announced its net profit after tax of Rs. 359.09 Cr in the most recent quarter.

Outlook:

Divi’s Laboratories Ltd is a buy call with a target of Rs. 2,200 and a stop loss of Rs. 2,030.

SRF Ltd (SRFL):

SRF Ltd has officially announced a consolidated sales of Rs. 1,807.45 Cr for the quarter finished on 31-12-2019, which is 6.19% up from its previous quarter sales of Rs. 1,702.17 Cr and -5.23% down from its previous year’s same quarter sales of Rs. 1,907.21 Cr. The firm has also announced its net profit after tax of Rs. 342.99 Cr in the most recent quarter.

Outlook:

SRF Ltd is a buy call with a target of Rs. 4,320 and a stop loss of Rs. 4,005.

Disclaimer: The perspectives and investment tips are given in this section are the expert’s own and not that of the website or its management. We encourage clients to check with certified experts before taking any position in the stocks/shares mentioned.

Related posts

Buy REC Ltd Future, Tata Steel Ltd & Hero MotoCorp Ltd

ravi

Buy Aurobindo Pharma Fut & Sell PVR Fut, REC Fut

jabili

Buy Ujjivan Financial, ICICI Bank & HCL Technologies Ltd

jabili